Translational drug safety and toxicology
3 European H2020 organizations list this as part of their work — 3 as their primary capability.
Most active in this area
- JANSSEN PHARMACEUTICA NV
Major pharmaceutical company contributing drug discovery data, compound libraries, and clinical expertise to large European health research consortia.
“Key contributor to eTRANSAFE, TransQST, and ADAPT-SMART — focused on computational toxicology, PBPK modelling, data sharing for preclinical-to-clinical safety translation.”
PrimaryBE81 projects - ASTRAZENECA AB
Global pharma company contributing drug safety data, clinical biomarkers, and AI-driven discovery to 58 H2020 health research consortia from Sweden.
“Core contributor to TransQST, eTRANSAFE, NeuroDeRisk, and ADAPT-SMART — all focused on improving preclinical-to-clinical safety prediction.”
PrimarySE58 projects - INSTITUT DE RECHERCHES INTERNATIONALES SERVIER
Servier's international research division contributing pharmaceutical industry expertise to drug safety, clinical trial platforms, and health data initiatives across Europe.
“Core contributor to eTRANSAFE (data integration for safety assessment), TransQST (quantitative systems toxicology), and PREMIER (environmental risk of medicines).”
PrimaryFR16 projects